Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Seres Therapeutics, Inc. , a leading microbiome therapeutics company, today announced that on April 5, 2023, the Compensation and Talent Committee of Seres’ board of directors granted... | April 7, 2023

Related Keywords

,Nasdaq ,Talent Committee Of Sere ,Seres Therapeutics Inc ,Seres Therapeutics ,Talent Committee ,Inducement Award Plan ,Inducement Plan ,Nasdaq Listing Rule ,Nc Stock Exchange ,News ,Information ,Press Release ,Heres ,Reading ,Icrobiome ,Herapeutics ,Oday ,Nnounced ,Hat ,N ,Pril ,The ,Compensation ,End ,Talent ,Committee ,F ,Board ,Irectors Mcrb Us81750r1023 ,